Rights and permissions
About this article
Cite this article
Additional treatment costs in US cancer trials “minimal”. Pharmacoecon. Outcomes News 417, 6 (2003). https://doi.org/10.1007/BF03276399
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276399